OxThera Investors
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
Investor Type:
Healthcare Company
Technology:
Advanced BioTech R&D
Founded Date:
2005
Industry:
PharmTech
Employee Number:
11-50
Headquarters:
Stockholm, Stockholms Lan, Sweden